2024-11-17 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Report

**1. Performance Comparison & Divergence:**

Colgate-Palmolive (CL) is a consumer goods company manufacturing and selling a wide range of household and personal care products.  Over the analyzed period, CL's cumulative return (45.57%) significantly underperformed the S&P 500 (VOO) return (123.86%). The difference is a negative 78.29%, placing it in the 8.79th percentile of historical relative performance against the S&P 500. This indicates consistent underperformance relative to the broader market.  The provided alpha and beta analysis shows mixed results, with alpha fluctuating between -0.3 and 0.7, suggesting periods of both outperformance and underperformance relative to the market, with a predominantly negative Beta.

**2. Recent Price Movement:**

* **Closing Price:** $93.56 (Last Market: $93.59)
* **5-Day Moving Average:** $91.91
* **20-Day Moving Average:** $94.32
* **60-Day Moving Average:** $100.20

The price is slightly below the 20-day moving average, suggesting a potential short-term downtrend.  It is significantly below the 60-day moving average, indicating a more pronounced longer-term downtrend.

**3. Technical Indicators and Expected Return:**

* **RSI:** 42.06 (Slightly below the oversold threshold of 30, indicating potential buying opportunity but not a strong signal).
* **PPO:** 0.09 (Positive, suggesting a bullish trend, but very weak signal close to zero).
* **20-Day Relative Divergence:** -5.33% (Short-term downward trend).
* **Expected Return:** 0.0% (This suggests that, based on the provided data, no significant excess return over the S&P 500 is expected from long-term (2+ years) investing in CL).

The last market price of $93.59 is negligibly higher than the closing price. No significant immediate price movements (sharp upswings or downswings) can be concluded from the provided data.

**4. Recent Financials and Outlook:**

The provided financial data reveals relatively stable revenue around $5B per quarter but relatively consistent EPS around $0.85-$0.90, with some minor fluctuations.  A comparison with analyst estimates for the most recent quarter (2024-10-25) is missing and would significantly improve the analysis.

**5. Financial Data Analysis (Missing from Provided Data):** Revenue and profitability appear stable, although profit margins show a slight downward trend. Equity and ROE exhibit significant fluctuations, suggesting potential volatility in the company's financial position.  Further analysis is needed to understand the drivers behind this volatility.  Missing data prevents deeper analysis of this information.


**6. News and Recent Issues:**

*(This section requires information from recent news sources like Shacknews and Finbold.  Please provide recent news articles for a complete analysis.)*  Lack of provided news articles prevents an accurate analysis.  This section should include a summary of recent earnings announcements, analyst ratings, and any significant market events affecting CL's stock price.


**7. Comprehensive Analysis:**

Colgate-Palmolive's stock performance has significantly lagged the S&P 500, indicating underperformance. While some technical indicators hint at potential buying opportunities (RSI slightly below oversold, positive PPO), the overall trend appears bearish based on moving averages and relative divergence.  Financial data displays some inconsistency, requiring further detailed analysis.  The absence of recent news and analyst opinions limits a comprehensive evaluation.  A conclusive recommendation regarding investment in CL requires more data regarding the latest earnings results, analyst estimates and forecasts, and a comprehensive market outlook.


**8. (Missing Information):**  The complete analysis is impossible without information from points 5, 6, and the last part of point 4.  Please provide the requested additional data for a comprehensive evaluation of Colgate-Palmolive's stock.
